Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th

@article{Morrison2001PercutaneousCI,
  title={Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th},
  author={Douglass A. Morrison and Gulshan Sethi and Jerome Sacks and William Henderson and Frederick L. Grover and Steven P. Sedlis and Rick A Esposito and Kodagundi B Ramanathan and Darryl S Weiman and Jorge Saucedo and Tamim Antakli and Venki Paramesh and Stuart Pett and Sarah E Vernon and Vladimir Birjiniuk and Frederick W Welt and Mitchell W. Krucoff and Walter Wolfe and John C. Lucke and Sundeep Mediratta and David Booth and Charles Barbiere and Dan Lewis},
  journal={Journal of the American College of Cardiology},
  year={2001},
  volume={38 1},
  pages={143-9}
}
BACKGROUND Percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) are being applied to high-risk populations, but previous randomized trials comparing revascularization methods have excluded a number of important high-risk groups. OBJECTIVES This five-year, multicenter, randomized clinical trial was designed to compare long-term survival among patients with medically refractory myocardial ischemia and a high risk of adverse outcomes assigned to either a CABG… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

Similar Papers

Loading similar papers…